Now that the cost for sequencing an entire genome has fallen under $1000, it’s likely that EHRs will soon need to interpret whole or partial genomes. EHRs and CDS systems will need to be smart about analyzing relevant genetic variant information when there is a change in the patient’s medical history or if new genetic guidance is issued. Interpreta Vice President for Quality and Risk Analytics Matt Yuill M.D. outlines why genomic profiles and numerous other data sources now require frequent interpretation to extract their clinical value in a February 2018 Healthcare Analytics News article.

Read the full article here